About Thomas Tillett
Form D filings for MBF Therapeutics from 2009 to 2024 list Thomas Tillett as president and director.
Thomas Tillett first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Tillett in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Tillett works with at each company, as listed on that company's latest Form D.
MBF Therapeutics, Inc. · Form D, Jan 8, 2024
DT
Dhiren Thakker
Director
JC
Joseph Connor
Director
AP
Aris Persidis
Director
LK
Lorraine Keller
Executive officer
CC
Christopher Cashman
Director